Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
Clinical trial NCT00636168 · COMPLETED
Trial details
- NCT number
- NCT00636168
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-30
- Primary completion
- 2013-07-26
- Enrollment
- 1211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.